Strata Critical Medical (NASDAQ:SRTA) Upgraded at B. Riley Financial

B. Riley Financial upgraded shares of Strata Critical Medical (NASDAQ:SRTA) to a strong-buy rating in a report released on Tuesday,Zacks.com reports.

Other equities analysts have also issued research reports about the company. Craig Hallum started coverage on Strata Critical Medical in a research report on Wednesday. They issued a “buy” rating and a $8.00 price target for the company. Weiss Ratings assumed coverage on shares of Strata Critical Medical in a research report on Tuesday. They set a “hold (c-)” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Strata Critical Medical currently has an average rating of “Buy” and an average target price of $8.00.

Strata Critical Medical Trading Down 3.0%

Strata Critical Medical stock opened at $4.25 on Tuesday. Strata Critical Medical has a 12 month low of $2.35 and a 12 month high of $6.02.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.